Drugs marked in yellow have text description.
- ACTEMRA /solution/: tocilizumab (162)
- ACTEMRA /solution/: tocilizumab (162)
- ACTEMRA /solution/: tocilizumab (80)
- ACTEMRA /solution/: tocilizumab (200)
- ACTEMRA /solution/: tocilizumab (400)
- BIMZELX /solution/: bimekizumab (160)
- BIMZELX /solution/: bimekizumab (160)
- COSENTYX /solution/: secukinumab (75)
- COSENTYX /solution/: secukinumab (150)
- ENSPRYNG /solution/: satralizumab (120)
- ILARIS /solution/: canakinumab (150)
- ILUMYA /solution/: tildrakizumab (100)
- JAMTEKI /solution/: ustekinumab (45)
- JAMTEKI /solution/: ustekinumab (90)
- KEVZARA /solution/: sarilumab (200)
- KEVZARA /solution/: sarilumab (150)
- KEVZARA /solution/: sarilumab (200)
- KINERET /solution/: anakinra (150)
- OMVOH /solution/: mirikizumab (100)
- OMVOH /solution/: mirikizumab (100)
- OMVOH /solution/: mirikizumab (20)
- SILIQ /solution/: brodalumab (210)
- SIMULECT /powder for solution/: basiliximab (20)
- SKYRIZI /solution/: risankizumab (150)
- SKYRIZI /solution/: risankizumab (150)
- SKYRIZI /solution/: risankizumab (360)
- SKYRIZI /solution/: risankizumab (60)
- SKYRIZI /solution/: risankizumab (90)
- SPEVIGO /solution/: spesolimab (60)
- STELARA /solution/: ustekinumab (45)
- STELARA /solution/: ustekinumab (90)
- STELARA I.V. /solution/: ustekinumab (5)
- SYLVANT /powder for solution/: siltuximab (100)
- SYLVANT /powder for solution/: siltuximab (400)
- TALTZ /solution/: ixekizumab (80)
- TALTZ /solution/: ixekizumab (80)
- TREMFYA /solution/: guselkumab (100)
- TREMFYA ONE-PRESS /solution/: guselkumab (100)
- WEZLANA /solution/: ustekinumab (45)
- WEZLANA /solution/: ustekinumab (90)
- WEZLANA /solution/: ustekinumab (45)
- WEZLANA I.V. /solution/: ustekinumab (5)
Found 42 matches.